Clinical trials
Active, not recruiting Phase 3 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,981 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 6 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 16 |
| 2012 | 12 |
| 2013 | 21 |
| 2014 | 28 |
| 2015 | 46 |
| 2016 | 32 |
| 2017 | 64 |
| 2018 | 97 |
| 2019 | 128 |
| 2020 | 163 |
| 2021 | 254 |
| 2022 | 243 |
| 2023 | 266 |
| 2024 | 304 |
| 2025 | 217 |
| 2026 | 43 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1,981 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 97 |
| National Cancer Institute (NCI) | 62 |
| Merck Sharp & Dohme LLC | 54 |
| Hoffmann-La Roche | 53 |
| Novartis Pharmaceuticals | 49 |
| Eli Lilly and Company | 47 |
| Janssen Research & Development, LLC | 37 |
| AbbVie | 33 |
| Pfizer | 26 |
| Amgen | 24 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 113 |
| Carcinoma, Non-Small-Cell Lung | 97 |
| Prostatic Neoplasms | 61 |
| Multiple Myeloma | 47 |
| Neoplasms | 41 |
| Obesity | 38 |
| Neoplasm Metastasis | 31 |
| Ovarian Neoplasms | 27 |
| Colorectal Neoplasms | 25 |
| Melanoma | 25 |
Trials
Showing 76 to 100 of 1,981. Each trial links to its page on Pharma Observatory.
1,881 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.